Physician profile
Alysia N Robichau
NPI 1912936279
$2,218.26
in general payments reported to CMS, 2019-2025
20 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $125 · 2021: $238 · 2022: $337 · 2023: $325 · 2024: $363 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854 · Education: $23.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.82 |
| Education | $23.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $562.01 | 2020-2025 | Evenity, Prolia, Otezla |
| Pacira Therapeutics, INC. | $282.09 | 2019-2021 | |
| Pfizer INC. | $277.10 | 2019 | |
| Bioventus LLC | $192.76 | 2019-2025 | Durolane, Durolane, Xcell |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $135.43 | 2023 | Seglentis |
| Horizon Therapeutics Plc | $120.09 | 2019 | |
| Astellas Pharma US INC | $96.92 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $77.41 | 2023-2024 | Exparel, Iovera, Zilretta |
| Ucb, INC. | $45.39 | 2022 | |
| Depuy Synthes Sales INC. | $42.78 | 2021-2023 | Orthovisc |
| Exact Sciences Corporation | $37.56 | 2023-2024 | Cologuard Collection Kit |
| Radius Health, INC. | $34.25 | 2021 | |
| Abbott Laboratories | $33.33 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $32.13 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $21.10 | 2020 | |
| Lilly USA, LLC | $20.51 | 2023 | Mounjaro |
| Ferring Pharmaceuticals INC. | $17.54 | 2022 | |
| Endo Pharmaceuticals INC. | $16.34 | 2019 | |
| Phadia US INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysia Robichau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.